Keyword : FDA
Zirabev as a representative of the largest family of biosimilars in oncology
How to select the most valuable anticancer drugs for reimbursement? Experience of ESMO and WHOAuthor:Poliakova D. Т. 13, № 1 (49)
|
|
|
|
|
Keyword : FDAHow to select the most valuable anticancer drugs for reimbursement? Experience of ESMO and WHOAuthor:Poliakova D. Т. 13, № 1 (49) |
|